Melanie Wurm
Boehringer Ingelheim (Austria)(AT)
Publications by Year
Research Areas
Virus-based gene therapy research, RNA Interference and Gene Delivery, Protein Degradation and Inhibitors, CRISPR and Genetic Engineering, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer(2006)641 cited
- → Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation(2007)433 cited
- → FANCI is a second monoubiquitinated member of the Fanconi anemia pathway(2007)277 cited
- → A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo(2022)197 cited
- → Targeting cancer with small-molecule pan-KRAS degraders(2024)141 cited
- → Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles(2019)63 cited
- → The influence of semen‐derived enhancer of virus infection on the efficiency of retroviral gene transfer(2010)46 cited
- → Synergistic activity of BET inhibitor BI 894999 with PLK inhibitor volasertib in AML in vitro and in vivo(2018)37 cited
- → Adaptation of topoisomerase I paralogs to nuclear and mitochondrial DNA(2009)27 cited
- → A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway(2021)23 cited